Mallinckrodt Pharmaceuticals
MNK
#10200
Rank
NZ$7.58 M
Marketcap
$0.57
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

EPS for Mallinckrodt Pharmaceuticals (MNK)

EPS in 2023 (TTM): -$199.64

According to Mallinckrodt Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$203.04. In 2021 the company made an earnings per share (EPS) of -$14.20 an increase over its 2020 EPS that were of -$18.76.

EPS history for Mallinckrodt Pharmaceuticals from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$199.64
2021-$14.20-24.31%
2020-$18.76-5.41%
2019-$19.84-72.67%
2018-$72.59-291.46%
2017$37.91797.22%
2016$4.23-34.03%
2015$6.41-207.61%
2014-$5.95-366.73%
2013$2.23

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$23.62-111.63%๐Ÿ‡บ๐Ÿ‡ธ USA
-$3.35-98.35%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
$14.34-107.06%๐Ÿ‡บ๐Ÿ‡ธ USA